In Regard to Spratt

Affiliations

¹ Institute of Cancer Research-Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom.
² Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
³ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom.
⁴ Institute of Cancer Research-Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom.

Comment

Anna C Wilkins et al. Int J Radiat Oncol Biol Phys. 2018.

. 2018 Dec 1;102(5):1596-1597.

doi: 10.1016/j.ijrobp.2018.08.007.

¹ Institute of Cancer Research-Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom.
² Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
³ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom.
⁴ Institute of Cancer Research-Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom.

No abstract available

Comment in

In Reply to Wilkins et al.
Spratt DE. Spratt DE. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1597-1598. doi: 10.1016/j.ijrobp.2018.08.008. Int J Radiat Oncol Biol Phys. 2018. PMID: 31014791 No abstract available.

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Wilkins AC, Gusterson B, Szijgyarto Z, Haviland J, Griffin C, Stuttle C, Daley F, Corbishley CM, Dearnaley DP, Hall E, Somaiah N; CHHiP Trial Investigators. Wilkins AC, et al. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):309-315. doi: 10.1016/j.ijrobp.2018.01.072. Epub 2018 Feb 3. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559283 Free PMC article. Clinical Trial.
Ki-67 Remains Solely a Prognostic Biomarker in Localized Prostate Cancer.
Spratt DE. Spratt DE. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):513-515. doi: 10.1016/j.ijrobp.2018.03.008. Int J Radiat Oncol Biol Phys. 2018. PMID: 29893267 No abstract available.